Cell-based aptamer selection for diagnosing cancer and predicting cancer progression |
| |
Authors: | Eunkyung Kim Pooja Dua Soyoun Kim |
| |
Institution: | 1. Department of Medical Biotechnology, Dongguk University, 3-26 Pil-Dong, 100-715, Jung-Gu, Seoul, Korea
|
| |
Abstract: | Antibodies are excellent molecular recognition agents for a wide range of applications therefore they have been used heavily in clinical assays such as disease diagnosis. More recently, aptamers have emerged as alternative capturing agents in a variety of applications including medical diagnosis, environmental toxicity detection, targeted drug delivery and viral therapeutics. Aptamers are ssDNA or RNA that form three dimensional structures and bind to the target molecules such as peptide, protein or small molecules. Aptamers are generated by in vitro process called “SELEX (Systematic Evolution of Ligands by Exponential Enrichment)”. Conventionally, SELEX is performed with immobilized target molecules such as proteins in column, filter or beads. However, for some targets like membrane proteins, it is very difficult or almost impossible to immobilize the target proteins in their active conformation. However, cell-based aptamer selection technology explain how it can be better than standard immobilization methods in brief. Here, we described the cell-specific aptamers selecting technology, called cell-based SELEX, for diagnosing disease and predicting disease progression, especially in the case of complex disease, like cancer. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|